AstraZeneca unveils new factory as part of multibillion-dollar investment in US manufacturing

AstraZeneca, as part of its ongoing $3.5 billion investment in American innovation, opened its first U.S.-operated cell therapy factory in Maryland to help treat cancer patients.The U.K-based pharmaceutical giant said the new $300 million plant in Rockville symbolizes its confidence in America’s role as a "global leader in science, manufacturing and economic growth.""We understand the importance of doing what we do because lives and health are at stake," Pam Cheng, executive vice president